Olympus FV1000 Livecell Confocal System

奥林巴斯 FV1000 Livecell 共聚焦系统

基本信息

  • 批准号:
    8053625
  • 负责人:
  • 金额:
    $ 43.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this proposal is to provide state-of-the-art confocal imaging capabilities to advance NIH-funded projects in the Cardio regenerative Research Program and Cellular and Molecular Arrhythmia Research Program at the University of Wisconsin-Madison. Ongoing research projects by investigators in these groups currently utilize confocal microscopy extensively, but the available dedicated instrument (Bio-Rad Micro radiance) has recently been retired (10 years old) because of lack of service support and high costs associated with additional repair. Furthermore, technological advances and new features in contemporary confocal microscopes provide a significant advance in imaging capabilities. A fundamental need for research in cardio regenerative medicine is to be able to track transplanted cells and determine their fate in cardiac muscle. The five channel detection provided by the FV1000 will assist cardio regenerative research projects by allowing the simultaneous detection of multiple distinct cell lineage-specific proteins to more clearly demarcate distinct cell types in repaired and regenerated myocardium. Furthermore, the spectral detection system provided by the Olympus FV1000 will allow a more accurate detection of specific fluorophores, minimizing cross-talk. Critical questions in basic arrhythmia research are increasingly focused on determining the trafficking of ion channel proteins and associated proteins to the surface membrane and determining the precise sub compartmentalization of these molecules in cardiomyocytes. The proposed Olympus FV1000 will enable dynamic tracking of the membrane trafficking of ion channels and associated proteins by enabling fluorescence recovery after photo bleaching (FRAP) experiments using the SIM (simultaneous laser light stimulation and imaging) functionality of the system. Additionally, the ability to perform combined cellular electrophysiology and confocal imaging experiments greatly enhances the functional information that can be obtained by these experiments using techniques such as dynamic fluorescence resonance energy transfer (FRET) during voltage clamp experiments and calcium imaging with simultaneous voltage clamp studies. Comparisons with other instruments on the market suggested that the Olympus FV1000 has the proven functionality at a competitive price for the specified needs with excellent service available. The necessary space, administrative support, supervision, and technical expertise are already in place. An advisory board consisting not only of users but also of experts in confocal imaging and cardiac biology will provide oversight. Institutional support from the School of Medicine and Public Health, Department of Medicine, and Division of Cardiovascular Medicine will provide a microscope manager and funds needed for maintenance and repair. Overall, the requested Olympus FV1000 microscope will significantly advance multiple research projects improving current imaging data acquisition as well as providing new functionality that will enable powerful new applications not possible on available equipment. PUBLIC HEALTH REVELANCE: Heart disease remains the most common cause of death in the United States. The requested confocal microscope will provide a powerful tool for research projects aimed at better understanding the cellular and molecular mechanisms of arrhythmias, a major cause of illness and sudden death. In addition, this microscope will enable pioneering research focused on identifying new strategies to repair and regenerate cardiac muscle following injury such as myocardial infarction.
描述(由申请人提供):本提案的长期目标是提供最先进的共聚焦成像能力,以推进美国国立卫生研究院资助的威斯康星大学麦迪逊分校的心脏再生研究项目和细胞和分子心律失常研究项目。这些小组的研究人员正在进行的研究项目目前广泛使用共聚焦显微镜,但可用的专用仪器(Bio-Rad Micro radiance)最近已经退役(10年),因为缺乏服务支持和额外维修相关的高成本。此外,当代共聚焦显微镜的技术进步和新功能提供了成像能力的重大进步。心脏再生医学研究的一个基本需求是能够追踪移植细胞并确定它们在心肌中的命运。FV1000提供的五通道检测将有助于心脏再生研究项目,允许同时检测多种不同的细胞系特异性蛋白,从而更清楚地划分修复和再生心肌中的不同细胞类型。此外,奥林巴斯FV1000提供的光谱检测系统将允许更准确地检测特定的荧光团,最大限度地减少串扰。心律失常基础研究的关键问题越来越集中在确定离子通道蛋白和相关蛋白到表面膜的运输以及确定这些分子在心肌细胞中的精确亚区隔化。拟议的奥林巴斯FV1000将通过使用系统的SIM(同步激光刺激和成像)功能,在光漂白(FRAP)实验后实现荧光恢复,从而实现离子通道和相关蛋白质的膜运输的动态跟踪。此外,结合细胞电生理和共聚焦成像实验的能力大大增强了这些实验可以获得的功能信息,这些实验使用的技术,如动态荧光共振能量转移(FRET)在电压钳实验和钙成像与同步电压钳研究。与市场上其他仪器的比较表明,奥林巴斯FV1000具有成熟的功能,具有竞争力的价格,满足特定需求,提供优质的服务。必要的空间、行政支持、监督和技术专长已经到位。咨询委员会不仅包括用户,还包括共聚焦成像和心脏生物学方面的专家,将提供监督。来自医学与公共卫生学院、医学系和心血管医学部的机构支持将提供显微镜管理人员和维护和维修所需的资金。总体而言,要求的奥林巴斯FV1000显微镜将显著推进多个研究项目,改善当前的成像数据采集,并提供新的功能,使强大的新应用不可能在现有设备上。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy J. Kamp其他文献

Engineering a robust and anisotropic cardiac-specific extracellular matrix scaffold for cardiac patch tissue engineering
为心脏补片组织工程设计坚固且各向异性的心脏特异性细胞外基质支架
  • DOI:
    10.1016/j.mbplus.2024.100151
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Te;Brandon Zhao;Richard Balbin;Sameeksha Sharma;Donggi Ha;Timothy J. Kamp;Yuxiao Zhou;Feng Zhao
  • 通讯作者:
    Feng Zhao
Human pluripotent stem cell-derived cardiomyocytes for safety pharmacology applications
  • DOI:
    10.1016/j.vascn.2009.04.004
  • 发表时间:
    2009-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Timothy J. Kamp
  • 通讯作者:
    Timothy J. Kamp
Génération de cardiomyocytes à partir de cellules souches pluripotentes humaines
人类多能细胞中心肌细胞的生成
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sean P. Palecek;Timothy J. Kamp;Xiaojun Lian
  • 通讯作者:
    Xiaojun Lian
Long QT Syndrome-Associated F97C and S141R Ca<sub>V</sub>-3 Mutations Exert Pleiotropic Effects on Cardiac L-Type Calcium Channels
  • DOI:
    10.1016/j.bpj.2011.11.708
  • 发表时间:
    2012-01-31
  • 期刊:
  • 影响因子:
  • 作者:
    Jason D. Foell;Jabe M. Best;David J. Tester;Michael J. Ackerman;Ravi C. Balijepalli;Timothy J. Kamp
  • 通讯作者:
    Timothy J. Kamp
Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model
非人类灵长类动物缺血/再灌注模型中免疫抑制的心脏细胞治疗中的肠道微生物群调节
  • DOI:
    10.1038/s41536-025-00390-6
  • 发表时间:
    2025-01-15
  • 期刊:
  • 影响因子:
    6.500
  • 作者:
    Hung-Chih Chen;Yu-Che Cheng;Marvin L. Hsieh;Po-Ju Lin;Emily F. Wissel;Theodore Steward;Cindy M. C. Chang;Jennifer Coonen;Timothy A. Hacker;Timothy J. Kamp;Patrick C. H. Hsieh
  • 通讯作者:
    Patrick C. H. Hsieh

Timothy J. Kamp的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy J. Kamp', 18)}}的其他基金

Cardiovascular Bioengineering 2021 Symposium
心血管生物工程2021研讨会
  • 批准号:
    10237721
  • 财政年份:
    2021
  • 资助金额:
    $ 43.25万
  • 项目类别:
Committed Cardiac Progenitors to Remuscularize the Failing Ischemic Heart
心脏祖细胞致力于使衰竭的缺血性心脏重新肌肉化
  • 批准号:
    9811091
  • 财政年份:
    2019
  • 资助金额:
    $ 43.25万
  • 项目类别:
Refining Cardiac Progenitor Cells for Myocardial Repair
精炼心脏祖细胞以修复心肌
  • 批准号:
    9109019
  • 财政年份:
    2015
  • 资助金额:
    $ 43.25万
  • 项目类别:
Refining Cardiac Progenitor Cells for Myocardial Repair
精炼心脏祖细胞以修复心肌
  • 批准号:
    8988235
  • 财政年份:
    2015
  • 资助金额:
    $ 43.25万
  • 项目类别:
Caveolae, T-type Calcium Channels and Cardiac Hypertrophy
小窝、T 型钙通道和心脏肥大
  • 批准号:
    8979699
  • 财政年份:
    2012
  • 资助金额:
    $ 43.25万
  • 项目类别:
SHARING IN THE DISCOVERY STEM CELL OUTREACH LEARNING LAB
在发现干细胞推广学习实验室中分享
  • 批准号:
    8358215
  • 财政年份:
    2011
  • 资助金额:
    $ 43.25万
  • 项目类别:
SHARING IN THE DISCOVERY STEM CELL OUTREACH LEARNING LAB
在发现干细胞推广学习实验室中分享
  • 批准号:
    8173111
  • 财政年份:
    2010
  • 资助金额:
    $ 43.25万
  • 项目类别:
Caveolae and L-type Calcium Channels in Cardiomyocytes
心肌细胞中的小凹和 L 型钙通道
  • 批准号:
    7208180
  • 财政年份:
    2007
  • 资助金额:
    $ 43.25万
  • 项目类别:
Embryonic Stem Cell-based Therapies for Myocardial Infarction
基于胚胎干细胞的心肌梗塞疗法
  • 批准号:
    7637137
  • 财政年份:
    2007
  • 资助金额:
    $ 43.25万
  • 项目类别:
Caveolae and L-type Calcium Channels in Cardiomyocytes
心肌细胞中的小凹和 L 型钙通道
  • 批准号:
    7439009
  • 财政年份:
    2007
  • 资助金额:
    $ 43.25万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
    WBP Fellowship
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 43.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了